ArticleMolecular cancer therapeutics2017

Resistance to RET-Inhibition in RET-Rearranged NSCLC Is Mediated By Reactivation of RAS/MAPK Signaling.

Sarah K Nelson-Taylor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.